Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy: a Multicentre, Double-blind, Double-dummy, Randomized Controlled Trial

NCT02231125 is registered in ClinicalTrials.gov with Chen Xiangmei as lead sponsor.

NCT NCT02231125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02231125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy: a Multicentre, Double-blind, Double-dummy, Randomized Controlled Trial
Lead sponsor
Chen Xiangmei
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2014
Completion date
December 31, 2017
Enrollment
1,600 (estimated)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy